scispace - formally typeset
L

Lluís Puig

Researcher at Autonomous University of Barcelona

Publications -  510
Citations -  16811

Lluís Puig is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Psoriasis & Medicine. The author has an hindex of 56, co-authored 427 publications receiving 13381 citations. Previous affiliations of Lluís Puig include Jikei University School of Medicine & Pompeu Fabra University.

Papers
More filters
Journal ArticleDOI

Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE study.

Kristian Reich, +9 more
- 01 Feb 2020 - 
TL;DR: Secukinumab is a fully human monoclonal antibody that selectively binds to and neutralizes interleukin‐17A.
Journal ArticleDOI

Cumulative Life Course Impairment: The Imprint of Psoriasis on the Patient's Life ☆

S. Ros, +2 more
- 01 Mar 2014 - 
TL;DR: A new concept, cumulative life course impairment (CLCI), captures the notion of the ongoing effect of a disease, providing a new paradigm for assessing the impact of psoriasis on quality of life (QOL) measures.
Journal ArticleDOI

Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic Arthritis.

Proton Rahman, +10 more
- 01 Dec 2016 - 
TL;DR: In this paper, the effects of ustekinumab on patient-reported outcomes (PROs) in PSUMMIT 1 and PSUMmit 2 patients with active psoriatic arthritis (PsA) who were methotrexate (MTX) naive, MTX experienced, or anti-tumor necrosis factor (TNF) experienced.
Journal ArticleDOI

Reiter's syndrome-like pattern in AIDS-associated psoriasiform dermatitis

Jorge Romaní, +3 more
- 01 Jul 1996 - 
TL;DR: A retrospective study on the clinical records of all human immunodeficiency virus (HIV)‐positive patients with psoriasiform dermatitis requiring systemic treatment finds that a distinctive clinical pattern has been reported in some cases.
Journal ArticleDOI

Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis.

Antonio Julià, +16 more
- 01 Aug 2015 - 
TL;DR: A highly significant association is found between PDE3A-SLCO1C1 and the clinical response to TNF blockers and the allele that was previously associated with the lack of response to rheumatoid arthritis was associated with a higher anti-TNF efficacy in psoriasis.